ID ACE_MESAU Reviewed; 1314 AA. AC Q50JE5; DT 30-AUG-2005, integrated into UniProtKB/Swiss-Prot. DT 07-JUN-2005, sequence version 1. DT 27-MAR-2024, entry version 83. DE RecName: Full=Angiotensin-converting enzyme {ECO:0000303|PubMed:17343204}; DE Short=ACE {ECO:0000303|PubMed:17343204}; DE EC=3.4.15.1 {ECO:0000250|UniProtKB:P12821}; DE AltName: Full=Dipeptidyl carboxypeptidase I; DE AltName: Full=Kininase II {ECO:0000250|UniProtKB:P12821}; DE AltName: CD_antigen=CD143; DE Contains: DE RecName: Full=Angiotensin-converting enzyme, soluble form {ECO:0000250|UniProtKB:P12821}; DE Flags: Precursor; GN Name=Ace {ECO:0000303|PubMed:17343204}; Synonyms=Dcp1; OS Mesocricetus auratus (Golden hamster). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; OC Cricetidae; Cricetinae; Mesocricetus. OX NCBI_TaxID=10036; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RX PubMed=17343204; DOI=10.1080/10425170600724816; RA Uchide T., Fujimori Y., Fukushima U., Uechi M., Sasaki T., Temma K.; RT "cDNA cloning of hamster angiotensin-converting enzyme and mRNA RT expression."; RL DNA Seq. 17:319-325(2006). CC -!- FUNCTION: Dipeptidyl carboxypeptidase that removes dipeptides from the CC C-terminus of a variety of circulating hormones, such as angiotensin I, CC bradykinin or enkephalins, thereby playing a key role in the regulation CC of blood pressure, electrolyte homeostasis or synaptic plasticity. CC Composed of two similar catalytic domains, each possessing a functional CC active site, with different selectivity for substrates. Plays a major CC role in the angiotensin-renin system that regulates blood pressure and CC sodium retention by the kidney by converting angiotensin I to CC angiotensin II, resulting in an increase of the vasoconstrictor CC activity of angiotensin. Also able to inactivate bradykinin, a potent CC vasodilator, and therefore enhance the blood pressure response. Acts as CC a regulator of synaptic transmission by mediating cleavage of CC neuropeptide hormones, such as substance P, neurotensin or enkephalins. CC Catalyzes degradation of different enkephalin neuropeptides (Met- CC enkephalin, Leu-enkephalin, Met-enkephalin-Arg-Phe and possibly Met- CC enkephalin-Arg-Gly-Leu) (By similarity). Acts as a regulator of CC synaptic plasticity in the nucleus accumbens of the brain by mediating CC cleavage of Met-enkephalin-Arg-Phe, a strong ligand of Mu-type opioid CC receptor OPRM1, into Met-enkephalin. Met-enkephalin-Arg-Phe cleavage by CC ACE decreases activation of OPRM1, leading to long-term synaptic CC potentiation of glutamate release (By similarity). Also acts as a CC regulator of hematopoietic stem cell differentiation by mediating CC degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP). Acts as a CC regulator of cannabinoid signaling pathway by mediating degradation of CC hemopressin, an antagonist peptide of the cannabinoid receptor CNR1. CC Involved in amyloid-beta metabolism by catalyzing degradation of CC Amyloid-beta protein 40 and Amyloid-beta protein 42 peptides, thereby CC preventing plaque formation. Catalyzes cleavage of cholecystokinin CC (maturation of Cholecystokinin-8 and Cholecystokinin-5) and CC Gonadoliberin-1 (both maturation and degradation) hormones. Degradation CC of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) and amyloid-beta CC proteins is mediated by the N-terminal catalytic domain, while CC angiotensin I and cholecystokinin cleavage is mediated by the C- CC terminal catalytic region (By similarity). CC {ECO:0000250|UniProtKB:P09470, ECO:0000250|UniProtKB:P12821}. CC -!- FUNCTION: [Angiotensin-converting enzyme, soluble form]: Soluble form CC that is released in blood plasma and other body fluids following CC proteolytic cleavage in the juxtamembrane stalk region. CC {ECO:0000250|UniProtKB:P12821}. CC -!- FUNCTION: [Isoform Testis-specific]: Isoform produced by alternative CC promoter usage that is specifically expressed in spermatocytes and CC adult testis, and which is required for male fertility. In contrast to CC somatic isoforms, only contains one catalytic domain. Acts as a CC dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus CC of substrates (By similarity). The identity of substrates that are CC needed for male fertility is unknown. May also have a glycosidase CC activity which releases GPI-anchored proteins from the membrane by CC cleaving the mannose linkage in the GPI moiety. The GPIase activity was CC reported to be essential for the egg-binding ability of the sperm. This CC activity is however unclear and has been challenged by other groups, CC suggesting that it may be indirect (By similarity). CC {ECO:0000250|UniProtKB:P09470, ECO:0000250|UniProtKB:P12821}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, CC when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion CC of angiotensin I to angiotensin II, with increase in vasoconstrictor CC activity, but no action on angiotensin II.; EC=3.4.15.1; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=angiotensin I + H2O = angiotensin II + L-histidyl-L-leucine; CC Xref=Rhea:RHEA:63560, ChEBI:CHEBI:15377, ChEBI:CHEBI:58506, CC ChEBI:CHEBI:147350, ChEBI:CHEBI:147392; EC=3.4.15.1; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63561; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=bradykinin + H2O = bradykinin(1-7) + L-Phe-L-Arg; CC Xref=Rhea:RHEA:71451, ChEBI:CHEBI:15377, ChEBI:CHEBI:132988, CC ChEBI:CHEBI:133147, ChEBI:CHEBI:147352; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71452; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + substance P = L-Leu-L-Met-NH2 + substance P(1-9); CC Xref=Rhea:RHEA:71459, ChEBI:CHEBI:15377, ChEBI:CHEBI:190692, CC ChEBI:CHEBI:190693, ChEBI:CHEBI:190700; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71460; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + substance P = Gly-L-Leu-L-Met-NH2 + substance P(1-8); CC Xref=Rhea:RHEA:71463, ChEBI:CHEBI:15377, ChEBI:CHEBI:190692, CC ChEBI:CHEBI:190694, ChEBI:CHEBI:190699; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71464; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + substance P = L-Phe-L-Phe-Gly-L-Leu-L-Met-NH2 + CC substance P(1-6); Xref=Rhea:RHEA:71471, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:190692, ChEBI:CHEBI:190696, ChEBI:CHEBI:190697; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71472; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + neurotensin = L-isoleucyl-L-leucine + neurotensin(1-11); CC Xref=Rhea:RHEA:71475, ChEBI:CHEBI:15377, ChEBI:CHEBI:147362, CC ChEBI:CHEBI:190704, ChEBI:CHEBI:190706; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71476; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=goralatide + H2O = L-lysyl-L-proline + N-acetyl-L-seryl-L- CC aspartate; Xref=Rhea:RHEA:71455, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:190701, ChEBI:CHEBI:190702, ChEBI:CHEBI:190703; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71456; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + Met-enkephalin = L-phenylalanyl-L-methionine + L- CC tyrosylglycylglycine; Xref=Rhea:RHEA:71483, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:189868, ChEBI:CHEBI:190708, ChEBI:CHEBI:190709; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71484; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + Leu-enkephalin = L-phenylalanyl-L-leucine + L- CC tyrosylglycylglycine; Xref=Rhea:RHEA:71487, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:190689, ChEBI:CHEBI:190708, ChEBI:CHEBI:190710; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71488; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + Met-enkephalin-Arg-Phe = L-arginyl-L-phenylalanine + CC Met-enkephalin; Xref=Rhea:RHEA:70675, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:189868, ChEBI:CHEBI:189869, ChEBI:CHEBI:189870; CC Evidence={ECO:0000250|UniProtKB:P09470}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70676; CC Evidence={ECO:0000250|UniProtKB:P09470}; CC -!- CATALYTIC ACTIVITY: [Isoform Testis-specific]: CC Reaction=Release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, CC when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion CC of angiotensin I to angiotensin II, with increase in vasoconstrictor CC activity, but no action on angiotensin II.; EC=3.4.15.1; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250|UniProtKB:P12821}; CC -!- COFACTOR: [Isoform Testis-specific]: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC Note=Isoform Testis-specific only binds 1 Zn(2+) ion per subunit. CC {ECO:0000250|UniProtKB:P12821}; CC -!- COFACTOR: CC Name=chloride; Xref=ChEBI:CHEBI:17996; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC Note=Binds 3 chloride ions per subunit. {ECO:0000250|UniProtKB:P12821}; CC -!- COFACTOR: [Isoform Testis-specific]: CC Name=chloride; Xref=ChEBI:CHEBI:17996; CC Evidence={ECO:0000250|UniProtKB:P12821}; CC -!- ACTIVITY REGULATION: The dipeptidyl carboxypeptidase activity is CC strongly activated by chloride. The dipeptidyl carboxypeptidase CC activity is specifically inhibited by lisinopril, captopril and CC enalaprilat. {ECO:0000250|UniProtKB:P12821}. CC -!- ACTIVITY REGULATION: [Isoform Testis-specific]: Strongly inhibited by CC lisinopril and captopril. {ECO:0000250|UniProtKB:P12821}. CC -!- SUBUNIT: Monomer and homodimer; homodimerizes following binding to an CC inhibitor (By similarity). Interacts with calmodulin (CALM1, CALM2 or CC CALM3); interaction takes place in the cytoplasmic region and regulates CC phosphorylation and proteolytic cleavage (By similarity). CC {ECO:0000250|UniProtKB:P12821, ECO:0000250|UniProtKB:P12822}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P12821}; CC Single-pass type I membrane protein {ECO:0000255}. Cytoplasm CC {ECO:0000250|UniProtKB:P09470}. Note=Detected in both cell membrane and CC cytoplasm in neurons. {ECO:0000250|UniProtKB:P09470}. CC -!- SUBCELLULAR LOCATION: [Angiotensin-converting enzyme, soluble form]: CC Secreted {ECO:0000250|UniProtKB:P12821}. CC -!- SUBCELLULAR LOCATION: [Isoform Testis-specific]: Cell membrane CC {ECO:0000250|UniProtKB:P12821}; Single-pass type I membrane protein CC {ECO:0000255}. Secreted {ECO:0000250|UniProtKB:P12821}. Note=The CC testis-specific isoform can be cleaved before the transmembrane region, CC releasing a soluble form. {ECO:0000250|UniProtKB:P12821}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative promoter usage; Named isoforms=2; CC Name=Somatic; CC IsoId=Q50JE5-1; Sequence=Displayed; CC Name=Testis-specific; Synonyms=ACE-T; CC IsoId=Q50JE5-2; Sequence=Not described; CC -!- TISSUE SPECIFICITY: Widely expressed with dominant expression in lung CC and kidney. {ECO:0000269|PubMed:17343204}. CC -!- PTM: [Angiotensin-converting enzyme, soluble form]: Produced following CC proteolytic cleavage by secretase enzymes that cleave the transmembrane CC form in the juxtamembrane stalk region upstream of the transmembrane CC region. Cleavage can take place at different sites of the juxtamembrane CC stalk region. {ECO:0000250|UniProtKB:P12821}. CC -!- PTM: Phosphorylated by CK2 on Ser-1307; which allows membrane retention CC (By similarity). Phosphorylated on tyrosine residues on its CC extracellular part, promoting cleavage by secretase enzymes and CC formation of the soluble form (Angiotensin-converting enzyme, soluble CC form) (By similarity). {ECO:0000250|UniProtKB:P12821, CC ECO:0000250|UniProtKB:P12822}. CC -!- SIMILARITY: Belongs to the peptidase M2 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB212958; BAD98304.1; -; mRNA. DR RefSeq; NP_001268510.1; NM_001281581.1. [Q50JE5-1] DR AlphaFoldDB; Q50JE5; -. DR SMR; Q50JE5; -. DR STRING; 10036.ENSMAUP00000016025; -. DR MEROPS; M02.001; -. DR MEROPS; M02.004; -. DR GlyCosmos; Q50JE5; 13 sites, No reported glycans. DR GeneID; 101824864; -. DR KEGG; maua:101824864; -. DR eggNOG; KOG3690; Eukaryota. DR OrthoDB; 2898149at2759; -. DR BRENDA; 3.4.15.1; 3239. DR Proteomes; UP000189706; Unplaced. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0005615; C:extracellular space; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW. DR GO; GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW. DR GO; GO:0031404; F:chloride ion binding; ISS:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0070573; F:metallodipeptidase activity; ISS:UniProtKB. DR GO; GO:0004222; F:metalloendopeptidase activity; ISS:UniProtKB. DR GO; GO:0008233; F:peptidase activity; ISS:UniProtKB. DR GO; GO:0008241; F:peptidyl-dipeptidase activity; ISS:UniProtKB. DR GO; GO:0002003; P:angiotensin maturation; ISS:UniProtKB. DR GO; GO:0010815; P:bradykinin catabolic process; ISS:UniProtKB. DR GO; GO:0042447; P:hormone catabolic process; ISS:UniProtKB. DR GO; GO:0042445; P:hormone metabolic process; ISS:UniProtKB. DR GO; GO:0001822; P:kidney development; ISS:UniProtKB. DR GO; GO:0008217; P:regulation of blood pressure; ISS:UniProtKB. DR GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB. DR GO; GO:0010814; P:substance P catabolic process; ISS:UniProtKB. DR CDD; cd06461; M2_ACE; 2. DR Gene3D; 1.10.1370.30; -; 1. DR InterPro; IPR001548; Peptidase_M2. DR PANTHER; PTHR10514; ANGIOTENSIN-CONVERTING ENZYME; 1. DR PANTHER; PTHR10514:SF27; ANGIOTENSIN-CONVERTING ENZYME; 1. DR Pfam; PF01401; Peptidase_M2; 2. DR PRINTS; PR00791; PEPDIPTASEA. DR SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 2. DR PROSITE; PS52011; PEPTIDASE_M2; 2. DR PROSITE; PS00142; ZINC_PROTEASE; 2. PE 2: Evidence at transcript level; KW Alternative promoter usage; Calmodulin-binding; Carboxypeptidase; KW Cell membrane; Cytoplasm; Disulfide bond; Glycoprotein; Hydrolase; KW Membrane; Metal-binding; Metalloprotease; Phosphoprotein; Protease; KW Reference proteome; Repeat; Secreted; Signal; Transmembrane; KW Transmembrane helix; Zinc. FT SIGNAL 1..35 FT /evidence="ECO:0000250|UniProtKB:P12821" FT CHAIN 36..1314 FT /note="Angiotensin-converting enzyme" FT /id="PRO_0000028536" FT CHAIN 36..1238 FT /note="Angiotensin-converting enzyme, soluble form" FT /evidence="ECO:0000250|UniProtKB:P12821" FT /id="PRO_0000028537" FT TOPO_DOM 36..1265 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1266..1282 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1283..1314 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 46..630 FT /note="Peptidase M2 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT DOMAIN 649..1228 FT /note="Peptidase M2 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT REGION 1221..1262 FT /note="Juxtamembrane stalk" FT /evidence="ECO:0000250|UniProtKB:P12821" FT REGION 1293..1314 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 397 FT /note="Proton acceptor 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT ACT_SITE 526 FT /note="Proton donor 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT ACT_SITE 995 FT /note="Proton acceptor 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT ACT_SITE 1124 FT /note="Proton donor 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 237 FT /ligand="chloride" FT /ligand_id="ChEBI:CHEBI:17996" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 396 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 400 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 424 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 535 FT /ligand="chloride" FT /ligand_id="ChEBI:CHEBI:17996" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 797 FT /ligand="chloride" FT /ligand_id="ChEBI:CHEBI:17996" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 835 FT /ligand="chloride" FT /ligand_id="ChEBI:CHEBI:17996" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 994 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 998 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 1022 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 1096 FT /ligand="chloride" FT /ligand_id="ChEBI:CHEBI:17996" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 1100 FT /ligand="chloride" FT /ligand_id="ChEBI:CHEBI:17996" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT BINDING 1133 FT /ligand="chloride" FT /ligand_id="ChEBI:CHEBI:17996" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT MOD_RES 1307 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P12821" FT CARBOHYD 44 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 60 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 80 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 117 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 166 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 324 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 515 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 683 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 701 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 720 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 766 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 948 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1197 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 163..171 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT DISULFID 365..383 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT DISULFID 551..563 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT DISULFID 763..769 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT DISULFID 963..981 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" FT DISULFID 1149..1161 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01355" SQ SEQUENCE 1314 AA; 151595 MW; 74E29238E87F157E CRC64; MGAASGQRGQ GPPSPLLLLW LSLLLLLLPP SPAPALDPGL QPGNFSADEI GAHLFAESYN SSAEQVIFQS TVASWAYDTN MTEENARLQE EAELIWQEFA EVWGKKAKEL FDAIRQNFTD SKLRRVIETI RTLGPANLPL ARRQQYNSLQ NNMNRIYSTS KVCLPNKTAT CWSLEPELTN ILASSRSYAK LLFAWESWHD VVGIPLKPLY QDFTALSNEA YKQDGFSDTG AYWRSAYDSP SFEETLEHLY HQLEPLYLNL HAYVRRALHR RYGDKYINLR GPIPAHLLGD MWAQSWDNIY DMVVPFPNKP NLDVTNTMVQ KGWNVTHMFR VAEEFFTSMG LSPMPPEFWA ESMLEKPTDG REVVCHASAW DFFNRKDFRI KQCTRITMEQ LSTVHHEMGH VQYYLQYKDL TVPLRRGANP GFHEAIGDVL ALSVSTPAHL HKIGLLDRVA NDLESDINYL LKMALEKIAF LPFGYLVDQW RWGVFSGHTP PSRYNFDWWY FRTKYQGICP PVVRNETHFD AGAKFHIPSG TPYIRYFVSF ILQFQFHQAL CKEAGHQGPL HQCDIYQSTQ AGAKLQRVLQ AGYSRPWQEV LKEMVGSDTL DAQALLEYFQ PVIRWLQEQN QRNGEVLGWP EYQWRPPLPD NYPEGIDLVT DETEAERFVE EYDRTARVLW NEYAEANWQY NTNITLEASK ILLQKNKKVA NHTLKYGTLA KKFDVSNFQN YTIKRIIKKV QNMDRAVLPP KELEEYNQIL MDMETTYSIA NVCYLNGTCL HLEPDLTNVM ATSRKYEELL WVWKSWRDKV GRAILPLFPK YVELSNKIAH LNGYADGGDS WRSSYESKSL EQDLEQLYQE LQPLYLNLHA YVRRSLHRHY GSQHINLDGP IPAHLLGNMW AQTWSNIYDL VAPFPSAPNL DATEAMIKQG WTPRRIFKEA DDFFTSLGLL PVSEEFWNKS MLEKPGDGRE VVCHASAWDF YNGKDFRIKQ CTSVNMEDLV IAHHEMGHIQ YFMQYKDLPV TFREGANPGF HEAIGDVLAL SVSTPKHLHS LNLLSSEGGG YEHDINFLMK MALDKIAFIP FSYLIDQWRW RVFDGSITKE NYNQEWWSLR LKYQGLCPPV PRSQDDFDPG SKFHVPANVP YIRYFVSFII QFQFHEALCR AAGHTGPLHK CDIYQSKEAG KLLADTMKMG YSKPWPEAMK LITGQPNMSA SAMMNYFKPL TEWLVTENRR HGETLGWPEY NWTPNTARSE GPFPESGRVN FLGMYLEPQQ ARVGQWVLLF LGVSLLVATL GLTHRLFSIR QHGHSLHRPH RGPQFGSEVE LRHS //